Efficacy and Safety of Cangrelor in Women Versus Men During Percutaneous Coronary Intervention: Insights From the Cangrelor versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION PHOENIX) Trial

BACKGROUND—: Cangrelor is an intravenous ADP receptor antagonist that leads to potent and reversible inhibition of platelet aggregation. The relative safety and efficacy of some antiplatelet drugs in women has been disputed. METHODS AND RESULTS—: The Cangrelor versus Standard Therapy to Achieve Opti...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Circulation
المؤلفون الرئيسيون: O’Donoghue, Michelle L., Bhatt, Deepak L., Stone, Gregg W., Steg, Ph. Gabriel, Gibson, C. Michael, Hamm, Christian W., Price, Matthew J., Prats, Jayne, Liu, Tiepu, Deliargyris, Efthymios N., Mahaffey, Kenneth W., White, Harvey D., Harrington, Robert A.
التنسيق: Artigo
اللغة:Inglês
منشور في: Lippincott Williams & Wilkins 2016
الموضوعات:
Original Articles
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC4894784/
https://ncbi.nlm.nih.gov/pubmed/26762525
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.115.017300
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة